In vitro studies on the mechanism by which (+)-norfenfluramine induces serotonin and dopamine release from the vesicular storage pool

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 358, Issue 3, 1998, Pages 323-327

  Gobbi, Marco ^a   Parazzoli, Alberto ^a   Mennini, Tiziana ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

(+) Norfenfluramine; Dopamine release; Serotonin release; Synaptosomes

Indexed keywords

ANOREXIGENIC AGENT; CALCIUM CHANNEL; DOPAMINE; FENFLURAMINE; NORFENFLURAMINE; PARGYLINE; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; IN VITRO STUDY; MALE; NEUROTRANSMITTER UPTAKE; NONHUMAN; RAT; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SYNAPSE VESICLE; SYNAPTOSOME;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BRAIN; CALCIUM; COAGULANTS; DOPAMINE; DRUG INTERACTIONS; MALE; NORFENFLURAMINE; RATS; RESERPINE; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SYNAPTOSOMES;

EID: 0031720323     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005260     Document Type: Article

References (24)

1. Andersen PH (1989) The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur J Pharmacol 166:493-504
2. Caccia S, Anelli M, Ferrarese A, Fracasso C, Garattini S (1993a) The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat. Eur J Pharmacol 233:71-77
3. Caccia S, Anelli M, Fracasso C, Frittoli E, Giorcelli P, Gobbi M, Taddei C, Garattini S, Mennini T (1993b) Anorectic effect and brain concentrations of d-fenfluramine in the marmoset: relationship to the in vivo and in vitro effects on serotonergic mechanisms. Naunyn Schmiedebergs Arch Pharmacol 347:306-312
4. 2+-dependent mechanism. Br J Pharmacol 121:1735-1743
5. Curzon G, Gibson EL, Oluyomi AO (1997) Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. Trends Pharmacol Sci 18:21-25
6. De Simoni MG, Juraszczyk Z, Fodritto F, De Luigi A (1988) Different effects of fenfluramine isomers and metabolites on extracellular 5-HIAA in nucleus accumbens and hippocampus of freely moving rats. Eur J Pharmacol 153:295-299
7. 3H]5-HT release from rat hippocampal synaptosomes. Neuropharmacology 33:833-835
8. Garattini S, Bizzi A, Caccia S, Mennini T (1992) Progress report on the anorectic affects of dexfenfluramine, fluoxetine and sertraline. Int J Obes Relat Metab Disord 16 [Suppl 3]:S43-S50
9. Gibson EL, Kennedy AJ, Curzon G (1993) d-fenfluramine-induced and d-norfenfluramine-induced hypophagia - differential mechanisms and involvement of postsynaptic 5-HT receptors. Eur J Pharmacol 242:83-90
10. 3H]serotonin. Naunyn Schmiedebergs Arch Pharmacol 345:1-6
11. 3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes. Eur J Pharmacol 238:9-17
12. Gobbi M, Bergami A, Caltavuturo C, Dalla Valle F, Mennini T, Caccia S (1996a) Effects of repeated oral doses of dexnorfenfluramine on 5-HT levels and 5-HT uptake sites in rat brain. Neurosci Lett 219:5-8
13. Gobbi M, Mancini L, Presti ML, Mennini T (1996b) Down-regulation of rat brain 5-HT uptake carriers after treatment with high doses of D-fenfluramine. Brain Res 730:165-172
14. Goldstein DS, Feuerstein G, Izzo JL, Kopin IJ, Keiser HR (1981) Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci 28:467-475
15. Gray EG, Whittaker VP (1962) The isolation of nerve endings from brain: an electron-microscope study of cell fragments derived by homogenization and centrifugation. J Anat 96:79-87
16. Mennini T, Borroni E, Samanin R, Garattini S (1981) Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotonin. Neurochem Int 3:289-294
17. Mennini T, Bizzi A, Caccia S, Codegoni A, Fracasso C, Frittoli E, Guiso G, Martin Padura I, Taddei C, Uslenghi A, Garattini S (1991) Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs. Naunyn Schmiedebergs Arch Pharmacol 343:483-490
18. Mennini T, Fracasso C, Cagnotto A, Bergami A, Frittoli E, Gobbi M, Caccia S, Garattini S (1996a) In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat. Naunyn Schmiedebergs Arch Pharmacol 353:641-647
19. Mennini T, Gobbi M, Crespi D, Cinquanta M, Frittoli E, Giorcelli P, Anelli M, Caccia S (1996b) In vivo and in vitro interaction of flunarizine with D-fenfluramine serotonergic effects. Pharmacol Biochem Behav 53:155-161
20. Mintz IM, Venema VJ, Swiderek KM, Lee TD, Bean BP, Adams ME (1992) P-type calcium channels blocked by the spider toxin ω-Aga-IVA. Nature 355:827-829
21. Oluyomi AO, Gibson EL, Barnfield AMC, Curzon G (1994) d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release. Eur J Pharmacol 264:111-115
22. Paez X, Hernandez L (1996) Simultaneous brain and blood microdialysis study with a new removable venous probe. Serotonin and 5-hydroxyindoleacetic acid changes after d-norfenfluramine or fluoxetine. Life Sci 58:1209-1221
23. Puig de Parada M, Parada MA, Pothos E, Hoebel BG (1995) d-fenfluramine, but not d-norfenfluramine, uses calcium to increase extracellular serotonin. Life Sci 56:PL415-PL420
24. Raiteri M, Angelini F, Levi G (1974) A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol 25:411-114